Skip to main content

Main menu

Home
Content
Subscriptions
Authors
Info
About
More
- Alerts
- Feedback
- Help
- SNMMI Journals

SNMMI
- JNM
- JNMT
- SNMMI Journals
- SNMMI

User menu

Subscribe
My alerts
Log in
My Cart

Search

Search for this keyword

Advanced search

SNMMI
- JNM
- JNMT
- SNMMI Journals
- SNMMI

Subscribe
My alerts
Log in
My Cart

Search for this keyword

Advanced Search

Home
Content
Subscriptions
Authors
Info
About
More
- Alerts
- Feedback
- Help
- SNMMI Journals

Follow JNM on Twitter
Visit JNM on Facebook
Join JNM on LinkedIn
Subscribe to our RSS feeds

Table of Contents

June 1, 2022; Volume 63,Issue supplement 2

PhysicianPharm_Oral

PhysicianPharm_Poster

Student_Oral

Student_poster

- - Radiopharmacy

Technologist_oral

Technologist_poster

In this issue

Journal of Nuclear Medicine

Vol. 63, Issue supplement 2

June 1, 2022

Table of Contents
Index by author

Search for this keyword

Sign up for alerts

Jump to

PhysicianPharm_Oral
PhysicianPharm_Poster
Student_Oral
Student_poster
Technologist_oral
Technologist_poster

Most Cited
Most Read

Initial Clinical Experience with ⁹⁰Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients
Total-Body PET Multiparametric Imaging of Cancer Using a Voxelwise Strategy of Compartmental Modeling
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with ¹⁷⁷Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort
Why We Did What We Did: PSMA PET/CT Selection Criteria for the VISION Trial
⁶⁸Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the ⁶⁸Ga-FAPI PET Prospective Observational Trial

© 2023 Journal of Nuclear Medicine